CMO Moves: Regulatory catalysts for drug manufacturing-April
Pharmaceutical Technology
JULY 14, 2022
In this ongoing series , we put a spotlight on contracts between pharma companies and contract manufacturing organizations (CMOs). This analysis is based on the GlobalData Pharma Intelligence Center’s Deals database and PharmSource reports.
Let's personalize your content